{"url_path":"/sec/ngne/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1404644/0001404644-26-000056-index.html","accession_number":"0001404644-26-000056","cik":"0001404644","ticker":"NGNE","issuer_name":"Neurogene Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1404644/0001404644-26-000056-index.html","primary_entity_key":"0001404644","primary_entity_name":"Neurogene Inc."},"word_count":82,"has_tables":true,"body_markdown":"Item 9.01Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNumber\n  Description\n\n99.1  \n[Press Release dated August 11, 2026](ngne_2qye26earningsrelease.htm)\n\n99.2\n[Corporate Presentation (August 2026)](a202608_ngnecorporatepre.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nNEUROGENE INC.\n\nDate: August 11, 2026By:/s/ Christine Mikail\n\nName: Christine Mikail\n\nTitle: President, Chief Financial Officer"}